Effect of Interferon-α Treatment of Chronic Hepatitis C on Health-Related Quality of Life
✍ Scribed by Christine M. Hunt; Jason A. Dominitz; Barbara Philips Bute; Bradford Waters; Umberto Blasi; Diane M. Williams
- Book ID
- 110377377
- Publisher
- Springer US
- Year
- 1997
- Tongue
- English
- Weight
- 99 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about 40% of patients and apparent eradication of infection in 7% to 40% of patients. In this report, we d
The relationship between stages of chronic hepatitis B liver disease and health-related quality of life (HRQoL) is an important aspect of the overall management of hepatitis B virus (HBV) infection, yet is not well characterized. Consequently we sought to examine HRQoL in HBV patients, stratified by
Alpha interferon is available worldwide as at least six dif-Alpha interferons have been used widely to treat chronic hepatitis C virus infection. These include recombinant inter-ferent products made by as many pharmaceutical companies. It is approved for human use in the European Union and the fero